Combination study of 1,24(S)-dihydroxyvitamin D2 and chemotherapeutic agents on human breast and prostate cancer cell lines
This BPC-157 TB-500 blend provides researchers with both compounds at a fixed 1:1 ratio in a single verified vial
Na + ,K + -ATPase activity is required both to support NKCC1 function, since NKCC1 operates as a secondary active transporter supported by Na + ,K + -ATPase-generated ion gradients, and to maintain conditions allowing inward channel-mediated transport
This guide is storage context for research materials, not medical or dosing advice
236.Kim Y-S, Ko MJ, Moon H, Sim W, Cho AS, Gil G, et al
Results/Outcome The scientific results demonstrate that ML-I can be formulated in TSL and USL and that bioactivity of the loaded cargo can be studied in an in vitro setting confirming the protective effect of the nanocarrier, the predicted behavior of the nanocarrier resulting in the proper cellular interaction (uptake and cell death) of the formulated ML-I